Cargando…
Photopharmacology of Proteolysis-Targeting Chimeras: A New Frontier for Drug Discovery
Photopharmacology is an emerging field that uses light to precisely control drug activity. This strategy promises to improve drug specificity for reducing off-target effects. Proteolysis-targeting chimeras (PROTACs) are an advanced technology engineered to degrade pathogenic proteins through the ubi...
Autores principales: | Zeng, Shenxin, Zhang, Hongjie, Shen, Zhengrong, Huang, Wenhai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987681/ https://www.ncbi.nlm.nih.gov/pubmed/33777902 http://dx.doi.org/10.3389/fchem.2021.639176 |
Ejemplares similares
-
Proteolysis targeting chimeras (PROTACs) come of age: entering the third decade of targeted protein degradation
por: Bond, Michael J., et al.
Publicado: (2021) -
Computer aided drug design in the development of proteolysis targeting chimeras
por: Tunjic, Tin M., et al.
Publicado: (2023) -
Photopharmacology
por: Sarma, Phulen, et al.
Publicado: (2017) -
Proteolysis targeting chimeras (PROTACs) in cancer therapy
por: Ocaña, Alberto, et al.
Publicado: (2020) -
Shining a Light on Proteolysis Targeting Chimeras
por: Teichmann, Ellen, et al.
Publicado: (2019)